<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font6" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
<text top="42" left="315" width="62" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="text"><b>Available online</b></text>
<text top="42" left="380" width="176" height="7" font="font2" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="text">http://breast-cancer-research.com/content/8/5/R53</text>
<text top="758" left="516" width="40" height="7" font="font2" id="p1_t3" reading_order_no="107" segment_no="14" tag_type="text">Page 7 of 9</text>
<text top="769" left="436" width="120" height="6" font="font3" id="p1_t4" reading_order_no="108" segment_no="15" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="85" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="1" tag_type="text">lack of specificity can delay early detection and treatment of</text>
<text top="97" left="57" width="240" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="1" tag_type="text">recurrent lesions [<a href="">8</a>]. The ultrasound examination is used as a</text>
<text top="109" left="57" width="240" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="1" tag_type="text">complementary follow-up imaging modality of the treated</text>
<text top="120" left="57" width="240" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="1" tag_type="text">breast, especially in radiodense breasts. This examination</text>
<text top="132" left="57" width="240" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="1" tag_type="text">does have high sensitivity if performed at regular intervals,</text>
<text top="144" left="57" width="240" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="1" tag_type="text">because of the detection of hypoechoic nodules within fibrous</text>
<text top="156" left="57" width="240" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="1" tag_type="text">hyperechoic tissue [<a href="">3</a>]. The sensitivity of ultrasound is user</text>
<text top="167" left="57" width="240" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="1" tag_type="text">dependent, however, and it is limited when evaluating small or</text>
<text top="179" left="57" width="180" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="1" tag_type="text">noninvasive lesions, especially in fatty breasts.</text>
<text top="203" left="57" width="240" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="4" tag_type="text">For these reasons, MRM is considered a useful additional</text>
<text top="214" left="57" width="240" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="4" tag_type="text">examination in patients with suspicion of recurrenc<a href="">e [7,8].</a></text>
<text top="226" left="57" width="240" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="4" tag_type="text">Progress in breast MRI has been limited by a lack of standard-</text>
<text top="238" left="57" width="240" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="4" tag_type="text">ization in the acquisition and interpretation of MRM images,</text>
<text top="250" left="57" width="240" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="4" tag_type="text">with some studies focusing on morphology (spatial resolution)</text>
<text top="261" left="57" width="240" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="4" tag_type="text"><a href="">[19] an</a>d other studies stressing kinetics (temporal resolution)</text>
<text top="273" left="57" width="32" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="4" tag_type="text"><a href="">[20,21].</a></text>
<text top="297" left="57" width="240" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="6" tag_type="text">In the present study, the multifactorial evaluation protocol pro-</text>
<text top="308" left="57" width="240" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="6" tag_type="text">posed by Fische<a href="">r and colleagues [1] w</a>as used to evaluate</text>
<text top="320" left="57" width="240" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="6" tag_type="text">enhancing lesions on the site of prior lumpectomy, based both</text>
<text top="332" left="57" width="240" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="6" tag_type="text">on their morphologic and kinetic characteristics, in an attempt</text>
<text top="344" left="57" width="240" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="6" tag_type="text">to standardize their evaluation. The number of true-negative</text>
<text top="355" left="57" width="240" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="6" tag_type="text">cases confirmed by histology (12 lesions) demonstrates that</text>
<text top="367" left="57" width="240" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="6" tag_type="text">12 unnecessary biopsies could have been avoided using this</text>
<text top="379" left="57" width="87" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="6" tag_type="text">multifactorial protocol.</text>
<text top="402" left="57" width="240" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="8" tag_type="text">The dynamic enhancement pattern, combined with morphol-</text>
<text top="414" left="57" width="240" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="8" tag_type="text">ogy, on contrast-enhanced MRI of breast masses, allows</text>
<text top="426" left="57" width="240" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="8" tag_type="text">reproducible lesion characterization<a href=""> [22], </a>and it is useful to dif-</text>
<text top="438" left="57" width="240" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="8" tag_type="text">ferentiate between benign and malignant lesions<a href=""> [21,23]. A</a></text>
<text top="449" left="57" width="240" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="8" tag_type="text">review of the literature has reported a sensitivity of more than</text>
<text top="461" left="57" width="240" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="8" tag_type="text">90%, and 85–100% specificity, for MRM to detect recurrence</text>
<text top="473" left="57" width="240" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="8" tag_type="text"><a href="">[7,10,24-26]. In th</a>e present study MRM correctly detected 8/</text>
<text top="485" left="57" width="240" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="8" tag_type="text">9 lesions on the surgical scar, all being infiltrating carcinomas.</text>
<text top="508" left="57" width="240" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="9" tag_type="text">The sole false-negative lesion was an infiltrating mucinous car-</text>
<text top="520" left="57" width="240" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="9" tag_type="text">cinoma. The lesion showed well-defined margins, regular</text>
<text top="532" left="57" width="240" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="9" tag_type="text">shape and homogeneous contrast enhancement, with a mod-</text>
<text top="543" left="57" width="240" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="9" tag_type="text">erate initial increase and a steady increase in later sequences</text>
<text top="555" left="57" width="240" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="9" tag_type="text">(graded as Fischer 2 and BI-RADS II). Other cases of infiltrat-</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="9" tag_type="text">ing mucinous breast cancer not detected by MRM have been</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="9" tag_type="text">desc<a href="">ribed [27,28].</a> The large amount of mucus slows the dif-</text>
<text top="590" left="57" width="240" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="9" tag_type="text">fusion of contrast medium through the entire tumor <a href="">[27,29],</a></text>
<text top="602" left="57" width="240" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="9" tag_type="text">and thereby induces gradual enhancement curves<a href=""> [30,31].</a></text>
<text top="614" left="57" width="240" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="9" tag_type="text">T2-weighted images have been considered useful because of</text>
<text top="626" left="57" width="240" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="9" tag_type="text">the very high signal intensity on these sequences compared</text>
<text top="637" left="57" width="240" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="9" tag_type="text">with other histologic<a href=""> types [29]</a>. In this case, the T2-weighted</text>
<text top="649" left="57" width="240" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="9" tag_type="text">sequence would probably have been helpful in detecting the</text>
<text top="661" left="57" width="240" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="9" tag_type="text">mucinous lesion. Nevertheless, this type of sequence is not</text>
<text top="673" left="57" width="240" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="9" tag_type="text">routinely performed in our institution because of the low rate of</text>
<text top="684" left="57" width="134" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="9" tag_type="text"><a href="">this histological type (1–4%) [29].</a></text>
<text top="708" left="57" width="240" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="13" tag_type="text">MRM in the present study found seven false-positive cases,</text>
<text top="720" left="57" width="240" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="13" tag_type="text">although all examinations were performed at least 6 months</text>
<text top="85" left="315" width="240" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="2" tag_type="text">after treatment. Other studies have demonstrated difficulties in</text>
<text top="97" left="315" width="240" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="2" tag_type="text">differentiating a recurrent tumor from postoperative changes</text>
<text top="109" left="315" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="2" tag_type="text">within 6 months after surgery<a href=""> [32] and with</a>in 12 months after</text>
<text top="120" left="315" width="240" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="2" tag_type="text">radiation therapy<a href=""> [33].</a> In the seven false-positive cases</text>
<text top="132" left="315" width="240" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="2" tag_type="text">described herein, the mean time between treatments and</text>
<text top="144" left="315" width="240" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="2" tag_type="text">MRM was 13 months, and only in two of these cases was the</text>
<text top="156" left="315" width="240" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="2" tag_type="text">time between the end of radiotherapy and MRM shorter than</text>
<text top="167" left="315" width="197" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="2" tag_type="text">12 months (6 months and 8 months, respectively).</text>
<text top="191" left="315" width="240" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">The high sensitivity in detection of multifocality, in particular for</text>
<text top="202" left="315" width="240" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">lesions located far from the scar, has influenced the type of</text>
<text top="214" left="315" width="240" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">repeat surgery (quadrantectomy versus mastectomy). These</text>
<text top="226" left="315" width="240" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">results are comparable<a href=""> with other studies [9] perfor</a>med on</text>
<text top="238" left="315" width="110" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="3" tag_type="text">smaller numbers of patients.</text>
<text top="261" left="315" width="240" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="5" tag_type="text">Of particular relevance is the very high negative predictive</text>
<text top="273" left="315" width="240" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="5" tag_type="text">value of MRM (98.7%), which indicates a very low likelihood of</text>
<text top="285" left="315" width="240" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="5" tag_type="text">new malignancy if MRM defines the lesion as benign. These</text>
<text top="297" left="315" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="5" tag_type="text">results suggest that lesions graded by MRM as Fischer I–II</text>
<text top="308" left="315" width="240" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="5" tag_type="text">(BI-RADS I–II) can be safely monitored with the usual yearly</text>
<text top="320" left="315" width="240" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="5" tag_type="text">follow-up. A repeat MRM examination after 6 months is recom-</text>
<text top="332" left="315" width="240" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="5" tag_type="text">mended for lesions graded as Fischer III (BI-RADS III), if there</text>
<text top="344" left="315" width="240" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="text">is no clinical suspicion of recurrence before 6 months. For</text>
<text top="355" left="315" width="240" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="5" tag_type="text">lesions graded higher than Fischer IV (BI-RADS IV–V), further</text>
<text top="367" left="315" width="196" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="5" tag_type="text">cytological or histological evaluation is mandatory.</text>
<text top="391" left="315" width="164" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="7" tag_type="text">One limitation of this study is the lack of </text>
<text top="391" left="479" width="28" height="9" font="font5" id="p1_t79" reading_order_no="76" segment_no="7" tag_type="text"><i>in situ </i></text>
<text top="391" left="507" width="49" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="7" tag_type="text">ductal carci-</text>
<text top="402" left="315" width="145" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="7" tag_type="text">noma in our series. Ductal carcinoma </text>
<text top="402" left="461" width="26" height="9" font="font5" id="p1_t82" reading_order_no="79" segment_no="7" tag_type="text"><i>in situ </i></text>
<text top="402" left="487" width="69" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="7" tag_type="text">is considered one</text>
<text top="414" left="315" width="240" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="7" tag_type="text">of the most common causes of false-negative results at MRM</text>
<text top="426" left="315" width="240" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="7" tag_type="text"><a href="">[34]</a>, and this can decrease the diagnostic accuracy of the</text>
<text top="438" left="315" width="240" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="7" tag_type="text">technique. In the present series we found no ductal carcinoma</text>
<text top="449" left="315" width="24" height="9" font="font5" id="p1_t87" reading_order_no="84" segment_no="7" tag_type="text"><i>in situ</i></text>
<text top="449" left="339" width="217" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="7" tag_type="text">, and this does probably justify the 93.8% overall sensi-</text>
<text top="461" left="315" width="240" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="7" tag_type="text">tivity with only one false-negative case. Another limitation was</text>
<text top="473" left="315" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="7" tag_type="text">that imaging examinations were evaluated by a single reviewer.</text>
<text top="485" left="315" width="240" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="7" tag_type="text">We therefore did not assess the interobserver variability in the</text>
<text top="496" left="315" width="130" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="7" tag_type="text">use of this multifactorial protocol.</text>
<text top="520" left="315" width="59" height="10" font="font6" id="p1_t93" reading_order_no="90" segment_no="10" tag_type="title"><b>Conclusion</b></text>
<text top="532" left="315" width="240" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="11" tag_type="text">This series demonstrates the high sensitivity and high specifi-</text>
<text top="543" left="315" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="11" tag_type="text">city of MRM in confirming or excluding recurrence at the prior</text>
<text top="555" left="315" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="11" tag_type="text">lumpectomy site, after conservative surgery and radiation ther-</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="11" tag_type="text">apy, when recurrence was already suspected either by mam-</text>
<text top="579" left="315" width="241" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="11" tag_type="text">mography (including the associated clinical examination) or by</text>
<text top="590" left="315" width="240" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="11" tag_type="text">ultrasonography. MRM has shown an overall high negative</text>
<text top="602" left="315" width="240" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="11" tag_type="text">predictive value (98.8%) in the detection of breast cancer,</text>
<text top="614" left="315" width="189" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="11" tag_type="text">including lesions not related to the surgical scar.</text>
<text top="637" left="315" width="240" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="12" tag_type="text">Despite the high accuracy of MRM in detecting recurrence on</text>
<text top="649" left="315" width="240" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="12" tag_type="text">the site of lumpectomy, its cost and low availability limit its use</text>
<text top="661" left="315" width="240" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="12" tag_type="text">for the routine follow-up of treated patients. In some</text>
<text top="673" left="315" width="241" height="9" font="font4" id="p1_t105" reading_order_no="102" segment_no="12" tag_type="text">conditions, however, as in the presence of radiodense breasts</text>
<text top="684" left="315" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="12" tag_type="text">and/or structural post-treatment changes, MRM represents an</text>
<text top="696" left="315" width="240" height="9" font="font4" id="p1_t107" reading_order_no="104" segment_no="12" tag_type="text">important diagnostic modality in support of the other</text>
<text top="708" left="315" width="240" height="9" font="font4" id="p1_t108" reading_order_no="105" segment_no="12" tag_type="text">traditional imaging modalities, and it can be considered con-</text>
<text top="720" left="315" width="157" height="9" font="font4" id="p1_t109" reading_order_no="106" segment_no="12" tag_type="text">clusive when showing negative findings.</text>
</page>
</pdf2xml>
